Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Understand the benefits of no fee cash back credit cards. Save money while enjoying rewards for your purchases.
25,488 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Lucid shares sank as new reports claim the EV maker is weighing drastic options, including a take-private or Chapter ...
Ripple’s XRP sits near $1.25 as US spot XRP ETFs show repeated $0.00 inflows, signaling muted investor interest amid ...
Rocket Lab’s stock slides after another delay to the Neutron rocket, dimming the year’s record narrative. Investors p...
In March 2026, investors seek cost-efficient, user-friendly options beyond M1 Finance. This report breaks down the to...
Oil prices rose as the IEA deployed an historic stock draw, yet Carlyle Group’s Currie argued there’s policy response...
As April 2026 approaches, investors face AI chatter, geopolitical headlines, and macro uncertainty. This guide offers...
Analysts project a multi-year path for novo nordisk (nvo) stock, supported by strong product momentum but tempered by...
Murphy Oil has surged about 48% in the past year, with shares trading near a 52-week high as Vietnam offshore project...
IREN leaps on a landmark NVIDIA AI Cloud contract and a parallel equity option, signaling a strategic pivot from cryp...
Four pure-play quantum stocks slid 6%–9% in a coordinated downturn, signaling a sector-wide rotation amid broader mar...
As Wall Street eyes the next stock split, ASML, Lilly, and TransDigm sit near the top of the list. Analysts say the o...